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Abstract 
Direct-to-consumer (DTC) genetic tests can be purchased over the internet.  Some companies claim 
to provide relative genetic risks for various diseases and thus encourage healthy behaviour.  There 
are concerns that exposure to such information may actually discourage healthy behaviour or 
increase health anxiety. An online survey was conducted (n=275).  Respondents were composed of 
individuals who had purchased a DTC genetic test and received their results (consumers, n=189), as 
well as individuals who were either awaiting test results or considering purchasing a test (potential 
consumers, n=86).  Consumers were asked if their health behaviour or health anxiety had changed 
after receiving their results.  Respondents’ current health behaviour and health anxiety were queried 
and compared. In total, 27.3% of consumers claimed a change in health behaviour, all either positive 
or neutral, with no reported cessation of any existing health behaviour.  A change in health anxiety 
was claimed by 24.6% of consumers, 85.3% of which were a reduction.  Consumers had significantly 
better health behaviour scores than potential consumers (p=0.02), with no significant difference in 
health anxiety.This study points towards an association between receipt of DTC genetic test results 
and increased adoption of healthy behaviours for a minority of consumers based on self-report, with 
more mixed results in relation to health anxiety.  
 
Background 
There are many companies that sell direct-to-consumer (DTC) genetic tests which provide 
consumers with a personalized genetic risk assessment for a variety of complex diseases (as opposed 
to tests which only focus on monogenic conditions, nutrigenomics, pharmacogenomics or ancestry 
testing) based on the screening of a large number of potential single nucleotide polymorphisms 
associated with these diseases (Bloss et al. 2011a; Bloss et al. 2011b; Samuel et al. 2010).  Tests are 
sold directly to consumers, normally with no need for the involvement of health care professionals 
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(Bloss et al. 2011a).  Although genetic counselling is occasionally provided [such as with Navigenics 
(Navigenics 2012)], it is by no means a requirement.  Many providers of DTC genetic tests claim that 
they will enable and encourage consumers to improve their health behaviour in relation to diseases 
for which they are at an increased risk (cf. 23andMe 2012; deCODEme 2012), although there is a 
large variation in the information provided and claims made on the websites of the different 
companies (Lachance et al. 2010; Singleton et al. 2012).  There are many concerns about DTC genetic 
tests in the literature.  Three common concerns are the limited clinical validity of the disease 
associations reported by many of the companies (Murray et al. 2010), the differences in genetic risk 
assessments provided by the various companies (Spencer et al. 2011) and the uncertain clinical 
significance of the mainly small changes to disease risk associated with the reported SNPs (Samuel et 
al. 2010).  
One main concern is with the effect the genetic risk information provided by the tests may have on 
the health behaviour and anxiety of consumers.  For example, a perceived high risk of disease may 
increase anxiety and a low risk may discourage healthy behaviour (Samuel et al. 2010).  A review of 
the relevant literature by McBride et al. (2010) concluded there was no evidence that anyone has 
been harmed by DTC genetic tests.  However, there is little research into the effects of DTC genetic 
tests on the health behaviour and anxiety of consumers and more is “desperately needed” (Bloss et 
al. 2011a).     
To the authors’ knowledge, the current study is one of only two studies to date that have examined 
consumers’ perceptions of behaviour change with a sample of “real” consumers of DTC genetic tests 
(i.e. individuals who have sought out and paid for a test, rather than those who have been offered a 
free or subsidized test) (for the other see Kaufman et al. 2012), and the only one to compare them 
with similar individuals who have either not yet purchased a test or not yet received any results.  
These are important contributions for two reasons.  Firstly, results from studies of participants who 
have been given a free or subsidised DTC genetic test, after they have been asked to participate in a 
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study, may not be generalizable to ordinary consumers of a relatively expensive new product.  
Secondly, a comparison of consumers of DTC genetic tests with individuals who have either not yet 
purchased a test or not yet received any results allows for a comparison between two similar groups 
who differ in the receipt of genetic test results.  
A review of the literature found three studies that have examined the effect of DTC genetic tests on 
groups of consumers.  In one of these studies (Kaufman et al. 2012), three of the main DTC genetic 
testing companies (Navigenics, deCODEme and 23andMe) were asked to dispatch a survey to a 
random sample of their customers.  After receiving their results (n=1048), one third claimed to be 
taking more care with their diet, 14% claimed an increase in their level of exercise and 16% claimed 
to have made changes to medication or supplements.  In another study (Gordon et al. 2011), 60 
participants who had been provided with a free test that analyzed genetic risk for eight diseases 
were interviewed after receiving their results.  Approximately one third claimed to have made 
behavioural changes, such as exercising more, increased diligence in use of sunscreen or checking 
high risk areas of their results with a healthcare professional.  In the third study (Bloss et al 2010; 
Bloss et al. 2011b), 2037 participants were invited to purchase a test at a heavily subsidized rate and 
given free access to genetic counselling.  After three months, no significant changes were found in 
participants’ level of anxiety, exercise behaviour or the amount of fat consumed in their diet. 
Despite the lack of research on the impact of DTC genetic tests for common complex diseases on 
consumer health behaviour, health anxiety and health outcomes, there is established research into 
the psychological and behavioural effects of genetic testing for single genes or disorders.  For 
example, a review of the literature on responses to BRCA testing for breast cancer risk found that 
there was no evidence of psychological harm after testing, and testing could be helpful in reducing 
worry about breast cancer (Hilgart et al. 2012).  A systematic review and meta-analysis of studies 
investigating the effect of genetic testing for smoking-related disease susceptibility found positive 
effects on participants’ cessation of smoking and motivation to do so in the short term, but not in 
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the long term (Smerecnik et al. 2012).  The researchers also found no negative effects (e.g. less 
motivation to stop smoking) if participants were not found to have a high genetic risk.  A review by 
Roberts et al. (2011) examined the effects of genetic testing for susceptibility to Alzheimer’s disease.  
They found no adverse psychological effects of testing.  Identified changes to health behaviour 
included an increase in the use of nutritional supplements and vitamins, and an increase in the 
purchase of long-term care insurance.  However, it is unclear how applicable these results are with 
regards to the impact of DTC genetic testing for common complex diseases on consumer health 
behaviour, health anxiety and health outcomes.   
Purpose of the Present Study 
The purpose of the present study was to examine consumers’ perceptions of the effect of genetic 
risk information, provided by DTC genetic tests, on their health behaviour and health anxiety.  The 
main research questions were: 
1. Do consumers believe that their health behaviour or health anxiety have changed due to 
receipt of genetic tests results, and if so, how have they changed? 
2. What are consumers and potential consumers perceptions of their current health behaviour 
and health anxiety, and is there a significant difference between the two groups? 
3. Is there a correlation between consumers’ perceived disease risk and their perceptions of 
their current health behaviour or health anxiety? 
 
 
 
Methods 
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Participants and Procedures 
As part of a larger study investigating the informational aspects of DTC genetic tests, an online 
survey was conducted to investigate several issues relating to DTC genetic tests, one of which was 
consumers’ perceptions of health behaviour and anxiety change after receipt of results.  Other issues 
investigated in the survey (but not reported in this paper) included: the information need of 
consumers (i.e. the information that consumers wished to know about DTC genetic tests, such as 
their accuracy or coverage), consumers’ information seeking behaviour (i.e. the techniques used by 
consumers to search for information about DTC genetic tests), sources of information consumers 
used to research DTC genetic tests and consumers’ opinions of the quality of information provided 
on the websites of DTC genetic testing companies (Egglestone et al. 2012).  Respondents were 
contacted via social media, which allowed both those who had purchased a test and received their 
results (consumers), and those who were considering purchasing a test and those who had 
purchased a test and not yet received their results (potential consumers) to be contacted.  The 
survey was conducted entirely in English, and a convenience sampling method was used.  The 
majority of respondents were found through the lists of “followers” on the Twitter pages of nine 
providers of DTC genetic tests.  Since private messages cannot be sent to Twitter users who do not 
“follow” you, only users with a link to a blog, about.me page or similar website in their Twitter user 
profile were contacted.  If an email address was provided on the linked webpage an email invitation 
was sent; if not a comment was left.  Other participants were contacted through messages posted 
on four relevant internet forums and eight relevant Facebook pages.  Several authors of relevant 
genetics blogs also posted invitations to their readers to participate.  Potential consumers were 
included in the study with the intention of allowing a comparison between two similar groups whose 
only major difference was the receipt of genetic test results.  In line with this intention, any 
consumers who had not yet received their results, while strictly not potential consumers in the 
literal sense, were combined with respondents who were considering purchasing a test to create the 
potential consumers group.  Respondents were asked to complete the survey if they had purchased, 
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or were considering purchasing, a test that included an estimate of genetic risk for various different 
diseases.  The choice of wording did result in 50 respondents who stated that their main interest was 
the genealogical, rather than the health, aspects of the tests.  However, these respondents were still 
exposed to the disease risk information, and their inclusion reflects consumers’ actual make-up 
rather than an artificially constrained sample.  
Two techniques were used to investigate consumers’ perceptions of changes to their health 
behaviour and health anxiety.  The first involved simply asking consumers if their health behaviour 
or health anxiety had changed in any way due to receiving their results, and if so, how (using open-
ended rather than close-ended questions).  These questions provided data on consumers’ 
perceptions about their health behaviour and health anxiety.  The second technique sought directly 
to compare the current health behaviour and health anxiety of the consumers and potential 
consumers groups, to identify any significant differences between the two groups.   
Ethical approval for the study was obtained from the Loughborough University Ethical Advisory 
Committee. 
Instrumentation 
There were a total of 44 items in the survey for respondents who had purchased a test, and 39 items 
for respondents who had not yet done so.    The survey was a mixture of open-ended and close-
ended questions.    
In order to assess whether consumers thought their health behaviour had changed due to receipt of 
DTC genetic test results, the following two questions were asked: 
Did your health-related behaviour change at all, either positively or negatively, due to receiving your 
test results? 
If yes, how did it change and have these changes lasted until now? 
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 Close-ended questions were used to assess respondents’ health behaviour in relation to six 
common health recommendations (inspiration was provided by NHS choices 2012; UCL 2012): a diet 
with moderate consumption of fat and salt and sufficient consumption of fibre, consumption of five 
portions of fruit and vegetables per day, smoking abstinence and sufficient levels of exercise.  For 
each health behaviour, respondents were assigned a one or a zero, depending on whether they 
normally followed or did not follow it respectively; these were added up to create an individual 
health behaviour score of between zero and six. 
Table 1 shows the questions and answer options used to assess health behaviour.  The answer 
options that showed the participant normally followed the health behaviour are marked with a star, 
with the exception of the questions relating to exercise.  For the questions relating to exercise, the 
requirement was a minimum of 150 minutes of moderate exercise per week, 75 minutes of vigorous 
exercise per week or an equivalent combination of the two (NHS Choices 2011). 
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Table 1: Questions used to assess health behaviour 
Question Answer Options 
What would you estimate the level of salt is in 
your diet? 
Lower than or equal to recommended levels*, 
higher than recommended levels or much higher 
than recommended levels. 
What would you estimate the level of fat is in 
your diet? 
Lower than or equal to recommended levels*, 
higher than recommended levels or much higher 
than recommended levels. 
What would you estimate the level of fibre is in 
your diet? 
Higher than or equal to recommended levels*, 
lower than recommended levels or much lower 
than recommended levels. 
Do you eat at least five items of fruit or 
vegetables a day?   
Never, rarely, some days, most days*, everyday* 
Do you smoke cigarettes? Never*, less than 1 per day*, between 1 and 10 
per day, between 11 and 20 per day,  
over 20 per day 
Do you smoke cigars or a pipe? Never*, very occasionally*, occasionally, often 
Approximately how much vigorous physical 
activity do you do per week? Examples of 
vigorous physical activity include running, 
jogging, racewalking, cycling at 10 mph or more, 
swimming laps, playing singles tennis, playing 
football (soccer), heavy gardening, walking with 
a heavy backpack, lifting weights, aerobic 
dancing and exercise classes. 
Length of time (minutes) 
None, 1 to 15, 16 to 30, 31 to 45, 46 to 60, over 
60 
Number of days per week 
1, 2, 3, 4, 5, 6, 7 
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Approximately how much moderate physical 
activity do you do per week? Examples of 
moderate physical activity include going for a 
brisk (at least 3 mph) or long walk, water 
aerobics, cycling slower than 10 mph, playing 
doubles tennis, ballroom dancing, general 
gardening and carrying heavy bags back from the 
shops. 
Length of time (minutes) 
None, 1 to 15, 16 to 30, 31 to 45, 46 to 60, over 
60 
Number of days per week 
1, 2, 3, 4, 5, 6, 7 
 
Approximately how much light physical activity 
do you do per week? Examples of light physical 
activity include going for a short walk, light 
gardening, DIY, light housework and using the 
stairs. 
Length of time (minutes) 
None, 1 to 15, 16 to 30, 31 to 45, 46 to 60, over 
60 
Number of days per week 
1, 2, 3, 4, 5, 6, 7 
 
In order to assess whether consumers thought their health anxiety had changed due to receipt of 
DTC genetic test results, the following two questions were asked: 
Did your level of health-related anxiety change at all due to receiving your test results? 
If yes, how did it change and have these changes lasted until now? 
To assess perceptions of current health anxiety, all respondents were asked to rate their health 
anxiety on two items (using a 10-point rating scale where 1=least anxious, and 10=most anxious): 
one item assessed their anxiety about their health in general, the other item assessed their anxiety 
about developing a serious disease.  These scores were compared between the consumer and 
potential consumer groups.  The wording of the question was: 
On a scale of 1 to 10 (1 least anxious, 10 most anxious), how anxious do you normally feel about: 
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a. The state of your health 
b. The possibility of developing a serious disease 
 
Several demographic questions were asked, including one on socioeconomic status, determined 
using the National Statistics Socio-economic Classification devised by the UK’s Office for National 
Statistics (Office for National Statistics 2012).  Based on their answers to four questions relating to 
their occupation (or if unemployed or retired from their previous occupation) a matrix was used to 
assign respondents to one of six categories: (1) managerial and professional occupations, (2) 
intermediate occupations, (3) small employers and own account workers, (4) lower supervisory and 
technical occupations, (5) semi-routine and routine occupations and (6) students. 
Consumers were asked to rate their general impression of their overall risk of contracting a serious 
disease based on their complete results.  The answer options were: a significantly lower than 
average risk of disease, a slightly lower than average risk of disease, an average risk of disease, a 
slightly higher than average risk of disease, and a significantly higher than average risk of disease. 
Data Analysis 
As stated above, for the purpose of the analysis all respondents who had purchased a test but not 
yet received their results were combined with the respondents who were considering purchasing a 
test to create a potential consumers group. 
Qualitative analysis. Consumers who stated that their health behaviour had changed were 
asked how it had changed with an open-ended question.  The answers to this question were post-
coded into categories, which were themselves derived from the answers to the question.  The 
categories are shown in table three in Results (with the exception of categories where n=1, which 
were combined into an “Other” category).   
12 
 
Consumers who stated that their health anxiety had changed were asked how it had changed with 
an open-ended question.  The answers to this question were post-coded into three categories:  an 
increase in health anxiety, a decrease in health anxiety or both an increase and a decrease in health 
anxiety. 
Quantitative analysis. The distributions of the health behaviour scores of the consumers and 
potentials consumers groups were compared using a two sample Kolmogrov-Smirnov test.  This test 
was chosen as the consumers group’s scores were not normally distributed, and it was deemed 
inappropriate to use a Mann-Whitney U test due to the large number of ties. 
The health behaviour scores were then split into two groups, a high score group and a low score 
group, to compare the proportion of consumers and potential consumers in each score group.  The 
high score group consisted of respondents with a health behaviour score of four, five or six.  The low 
score group consisted of respondents with a health behaviour score of zero, one, two or three.  The 
proportion of consumers and potential consumers in each score group was compared with a two-
sided Pearson’s Chi-Square test. 
The percentage of consumers and potential consumers who were assessed as normally following the 
separate individual health behaviours were compared with a two-sided Pearson’s Chi-Square test. 
In order to determine if the significant difference between consumers and potential consumers in 
health behaviour scores was due to underlying demographic variables, a two-sided Fisher’s Exact 
test was used to identify any significant differences in the proportion of the consumers and potential 
consumers groups in each demographic included in the survey (only respondents who had answered 
enough questions to be given a health behaviour score were included).  A Fisher’s Exact test was 
used instead of a Pearson’s Chi-Square test due to the small cell size for some of the categories.  For 
three of the demographic variables (socioeconomic status, ethnicity and country of residence), a 
large majority of respondents were in one category, with a corresponding small n in the other 
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categories.  Therefore the categories for these demographics were collapsed, to compare the 
managerial and professional occupations category against the other categories combined (for 
socioeconomic status), to compare Caucasian ethnicity against other ethnicities combined (for 
ethnicity) and to compare residency in USA against residency in all other countries combined (for 
country of residence). The health behaviour scores were then weighted to control for the different 
demographic variables and compared with a two sample Kolmogrov-Smirnov test.  As above, the 
categories for socioeconomic status, ethnicity and country of residence were collapsed, due to the 
large number of respondents in one category in each of the three demographic variables.  A 
stepwise multiple regression was then performed in an attempt to build a model of all predictor 
variables with health behaviour as the criterion variable.  As above, the categories for socioeconomic 
status, ethnicity and country of residence were collapsed, due to the large number of respondents in 
one category in each of the three demographic variables. 
The distributions of the health anxiety scores of the consumers and potentials consumers groups 
were compared using a two sample Kolmogrov-Smirnov test.  This test was chosen as the consumers 
group’s scores were not normally distributed, and it was deemed inappropriate to use a Mann-
Whitney U test due to the large number of ties. 
In order to determine if consumers’ perceived risk was correlated with their health behaviour score 
or health anxiety scores, the five answer options for the question on perceived risk were assigned an 
ordinal rank from one (significantly lower than average risk of disease) to five (significantly higher 
than average risk of disease).  Since these were ordinal ranks, a Spearman’s Rank correlation was 
used.   
Results 
There were 275 usable responses, 189 completed by respondents who had purchased a test and 
received their results, 22 by respondents who had purchased a test but had not yet received their 
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results and 64 by respondents who were considering purchasing a test.  Fifty respondents stated 
that their only reasons for pursuing DTC genetic tests were genealogical.  However, all respondents 
who had purchased a test had purchased one which included estimated genetic risks for more than 
one disease. 
In order to increase the response rate, all questions were voluntary.  Therefore, all results refer only 
to respondents who supplied enough data to be included in the particular analysis the result refers 
to, with percentages referring to the percentage of respondents included in the analysis rather than 
the total number of respondents.  The same is true for descriptive statistics.   
As stated above (see methods), for the purpose of the analysis all respondents who had purchased a 
test but not yet received their results were combined with respondents who were considering 
purchasing a test to create a potential consumers group.  The health behaviour scores of these two 
groups were compared using an independent samples t-test in order to assess their compatibility.  
This test was chosen as the scores for both groups were normally distributed.  The mean health 
behaviour scores for those who had not purchased a test was 3.67 and the mean of those who had 
not yet received their results was 3.58, a difference of 0.09.  The mode for both groups was 3, with 
almost identical standard deviation (1.37, 1.35).  An independent samples t-test found no significant 
difference between the two (p=0.81). 
Respondent Demographics 
In total, 62.7% of the respondents were male and 37.3% female.  The vast majority (84.6%) of 
respondents described themselves as Caucasian or White.  This was followed by mixed race with 
6.7% of respondents.  Respondents resided in a wide variety of countries, 22 in total.  A large 
majority (70.5%) resided in the USA, followed by the UK (9.6%), Canada (6.5%) and Australia (3.1%).  
The mode age group was 30-44 with 33.5% of respondents, the mode education level was a 
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postgraduate degree with 53.6% of respondents and the mode socioeconomic category was 
managerial and professional occupations (see methods) with 83.5% of respondents. 
Table 2 shows the demographics of the consumers and potential consumers groups.  Both groups 
had the same mode group for gender, education level, socioeconomic category, country of residence 
and ethnicity.  
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Table 2: Respondent Demographics (N=275) 
Demographic  Consumers Potential 
Consumers 
  n=189 n= 86 
  Percentage (n) Percentage (n) 
Gender Male 63.0 (114) 62.2 (51) 
 Female 37.0 (67) 37.8 (31) 
Age group 18-29 22.0 (40)  45.7 (37) 
 30-44 31.9 (58)  37.0 (30) 
 45-60 27.5 (50)  13.6 (11) 
 60+ 18.7 (34)  3.7 (3) 
Education level1 High school 3.4 (6) 3.7 (3) 
 Post-high school 2.2 (4) 4.9 (4) 
 Bachelors degree 39.1 (70) 42.0 (34) 
 Postgraduate degree 55.3 (99) 49.4 (40) 
Socioeconomic 
category 
Managerial and 
professional occupations 
86.4 (152) 77.2 (61) 
 Intermediate occupations 4.0 (7) 5.1 (4) 
 Small employers and own 2.8 (5) 6.3 (5) 
                                                          
1 Education level refers to respondents who have started but not necessarily completed that level of education  
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account workers 
 Lower supervisory and 
technical occupations 
1.7 (3) 1.3 (1) 
 Semi-routine and routine 
occupations 
1.1 (2) 1.3 (1) 
 Students 4.0 (7) 8.9 (7) 
Country of 
residence 
USA 71.8 (130) 67.5 (54) 
UK 9.4 (17) 10.0 (8) 
Canada 6.6 (12) 6.3 (5) 
Australia 3.9 (7) 1.3 (1) 
Other 8.3 (15) 15.0 (12) 
Ethnicity Caucasian 84.2 (149) 85.5 (65) 
 Mixed-race 7.3 (13) 5.3 (4) 
 Asian 2.8 (5) 9.2 (7) 
 Other 5.6 (10) 0 (0) 
 
Health Behaviour 
When asked whether their health behaviour had changed due to receiving their test results, 27.3% 
(n=50) of consumers stated that it had and 72.7% (n=133) stated that it had not.  Out of the fifty 
consumers who stated that their behaviour had changed, 45 (90%) described how it had the 
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changed.  Table 3 shows these changes in health behaviour and the percentage of respondents who 
mentioned each (some respondents mentioned more than one change to health behaviour).  The 
most common change was “healthier diet” (53.3%), followed by “more exercise” (26.7%) and “taking 
vitamins or supplements” (13.3%).     
 
Table 3: Consumers’ self-reported changes to health behaviour after receiving DTC genetic 
test results (n=45)a 
Change in Health Behaviour Percentage (N) 
Healthier diet 53.3 (24) 
More exercise 26.7 (12) 
Taking vitamins or supplements 13.3 (6) 
Preventative checks such as eye tests 8.9 (4) 
Looking into high risk items (either research, talking with doctor or medical tests)  6.7 (3) 
Stopped or reduced caffeine intake 6.7 (3) 
Lost weight 6.7 (3) 
Generally more health conscious 6.7 (3) 
Generally reducing risk conditions 4.4 (2) 
Other (e.g. wearing sunglasses) 15.6 (7) 
 
Table 4 shows the health behaviour scores for the consumers and potential consumers groups.  
 
 
                                                          
a Responses were not mutually exclusive and therefore add up to more than the number of respondents (45) 
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Table 4: Health behaviour scores of the consumers and potential consumers groupsa 
(N=216) 
Health behaviour score Consumers 
Percentage (n) 
Potential consumers 
Percentage (n) 
0 1.3 (2) 1.6 (1) 
1 2.0 (3) 4.7 (3) 
2 11.2 (17) 9.4 (6) 
3 13.2 (20) 34.4 (22) 
4 24.3 (37) 20.3 (13) 
5 30.9 (47) 21.9 (14) 
6 17.1 (26) 7.8 (5) 
Total 100 (152) 100 (64) 
 
The consumers’ scores were generally higher than the potential consumers’, with a mode of five and 
three respectively.  The mean scores were 4.18 and 3.64 respectively, a difference of 0.54.  A two 
sample Kolmogrov-Smirnov test found a significant difference between the distribution of health 
behaviour scores in the two groups (p=0.02).   
The scores were then split into two groups: a high score group and a low score group.  A two-sided 
Pearson’s Chi-Square test showed that there was a significant difference between the proportion of 
consumers and potential consumers in each score group X²(1, n = 216) = 10.01, p = 0.00, with 72.4% 
of consumers and 50.0% of potential consumers in the high score group, compared with 27.6% of 
consumers and 50.0% of potential consumers in the low score group. 
                                                          
a See methods 
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Table 5 shows the percentage of respondents in the consumers and potential consumers groups 
who were classified as normally following each health behaviour.  For both groups the health 
behaviour normally followed by the highest percentage of respondents was smoking abstinence, 
followed by sufficient fibre intake and sufficient exercise.  
Table 5: Percentage of respondents in consumers and potential consumers groups who 
were classified as normally following each health behaviour (n=263) 
Health behaviour Consumers 
Percentage (n) 
Potential consumers 
Percentage (n) 
Smoking abstinence 92.7 (166) 93.8 (76) 
Sufficient fibre intake 74.0 (125) 64.5 (49) 
Sufficient exercise 66.3 (114) 61.0 (47) 
Moderate salt intake 63.7 (109) 55.1 (38) 
Moderate fat intake 57.1 (101) 50.7 (37) 
Sufficient fruit and vegetable intake 53.6 (97) 38.8 (31) 
 
With the exception of smoking abstinence (where the proportions were almost identical), for each 
health behaviour a higher percentage of the consumers group normally followed the health 
recommendations than the potential consumers group, although the only significant difference was 
for fruit and vegetable intake.  A two-sided Pearson’s Chi-Square test found a significant difference 
between the two groups in the percentage who normally had a sufficient fruit and vegetable intake 
x²(1, n = 261) = 4.89, p = 0.03, but not in the percentage who normally had a moderate salt intake, a 
moderate fat intake, sufficient fibre intake, sufficient exercise or who were normally abstinent from 
smoking. 
Respondent demographic variables (age, proportion in the managerial and professional occupations 
socioeconomic category, gender, proportion of Caucasian ethnicity, education level , proportion 
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residing in the USA) were analysed to determine whether they accounted for the difference in health 
behaviour scores.  A two-sided Fisher’s Exact test found one significant difference between the 
consumers and potential consumers groups for age (p = 0.00), with consumers significantly more 
likely to be in an older age group than potential consumers.  Significant differences were found 
between the consumers and potential consumers groups when weighted for age (p = 0.03), two 
socioeconomic categories (the managerial and professional occupations category versus the other 
categories combined) (p = 0.03), ethnicity (Caucasian versus other ethnicities combined) (p = 0.05), 
education level (p = 0.03) and country of residence (USA versus other countries combined) (p = 
0.01).  A stepwise multiple regression was then performed in an attempt to build a model of all 
predictor variables for health behaviour scores.  Table 6 shows the results of this analysis.  The only 
significant predictor variable was membership in consumers or potential consumers group (B = -
0.48, SE B = -0.16, p = 0.03).   
Table 6: Results of multiple regression analysis  
Variable  Coefficient P 
Membership of consumers or potential 
consumers group 
B = -0.48 
SE B = -0.16 
0.03 
Gender Beta In = -0.14 0.06 
Education Level Beta In = 0.12 0.09 
Membership of managerial and professional 
occupations socioeconomic category 
Beta In = -0.08 0.28 
Residence in USA Beta In = -0.06 0.39 
Caucasian Ethnicity Beta In = 0.05 0.47 
Age Group Beta In = 0.12 0.67 
N   
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Health Anxiety 
When asked whether their health anxiety had changed due to receiving their results, 24.6% (n=45) 
stated that it had and 75.4% (n=138) stated that it had not.  Of those whose anxiety changed, 75.6% 
(n=34) described how it had changed; 85.3% (n=29) stated that their anxiety had decreased, three 
individuals reported that it had increased and two stated that it had both increased and decreased.  
The vast majority of respondents who described how their health anxiety had changed reported that 
it had only changed by a small amount. 
For general anxiety about health, the mean score for the consumers group was 3.80 and for the 
potential consumers group it was 4.22, a difference of 0.42.  The mode score for both groups was 2.  
A two sample Kolmogrov-Smirnov test found no significant difference in the distribution of anxiety 
scores between the two groups (p=0.63). 
For anxiety about developing a serious disease, the mean score for the consumers group was 3.52 
and for the potential consumers group it was 3.92, a difference of 0.40.  The mode score for both 
groups was 2.  A two sample Kolmogrov-Smirnov test found no significant difference in the 
distribution of anxiety scores between the two groups (p=0.30). 
Perceived Risk 
Table 7 shows consumers’ reported perception of their overall risk of serious disease based on their 
DTC genetic test results.  The results follow a rough bell curve, with over half of consumers reporting 
an impression of an average risk of disease.   
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Table 7: Consumers’ reported perceived risk of serious disease based on DTC genetic test 
results (n=171) 
Impression of disease risk Percentage (n) 
Significantly lower than average risk of disease 2.9 (5) 
Slightly lower than average risk of disease 26.3 (45) 
Average risk of disease 52.0 (89) 
Slightly higher than average risk of disease 14.0 (24) 
Significantly higher than average risk of disease 4.7 (8) 
 
Using Spearman’s Rank correlation, no significant correlation was found between perceived risk and 
health behaviour score (r = -0.08, n = 141, p = 0.36, two-tailed), general anxiety about health (r = 
0.10, n = 165, p = 0.20, two-tailed) or anxiety about developing a serious disease (r = 0.15, n = 165, p 
= 0.06, two-tailed).  
Discussion 
As stated earlier, to the authors’ knowledge the current study is one of only two studies whose 
participants were “real” consumers of DTC genetic tests (for the other see Kaufman et al. 2012).  
Also, a unique aspect of the present study is the inclusion of a group of respondents who had not 
received any DTC genetic test results (the potential consumers group), which was composed of 
respondents who had purchased a test but not yet received their results and respondents who had 
not purchased a test but were seriously considering doing so.  The inclusion of a potential consumers 
group is an important contribution, as respondents from this group were similar in terms of 
demographics and health related issues (such as interest in DTC genetic tests) to consumers who 
have received their results.   This allowed an investigation into consumers’ perceptions of health 
behaviour and anxiety change after receiving their results, by comparing the two groups’ 
perceptions of their current health behaviour and anxiety.  Although causation can never be 
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established from a cross-sectional survey, the use of the two techniques to investigate consumers’ 
perceptions of changes to health behaviour and anxiety after receipt of DTC genetic test results (i.e. 
both asking if changes had occurred and comparing perceptions of current behaviour and anxiety), 
the repeat of the significance tests with demographic weighting and the use of stepwise multiple 
regression to identify predictors of health behaviour adds validity to the results.   
With regard to reported changes to health behaviour, the percentage of consumers who reported a 
change (27.3%) was similar to that of Gordon et al. (2011), who found that approximately one third 
of respondents reported changes.  It is not clear why almost three quarters of respondents in the 
current study reported making no changes to their health behaviour.  In the study conducted by 
Gordon et al. (2011), the most common reasons given by participants for making no behavioural 
changes were that they were already practising healthy behaviours, they had not been found to be 
at an increased risk for any disease tested or that they were simply not surprised by the results.  
These explanations may also apply to the current study.  Indeed, with regard to participants already 
practising healthy behaviours, even amongst the potential consumers group half of the respondents 
self-reported as following four, five or six of the health behaviours, leaving little room for 
improvement.  However, no information on these issues was collected in the survey, so it is only 
possible to speculate. 
The total percentage of respondents who reported a change in health behaviour in the study by 
Kaufman et al (2012) is not clear, but many of the reported changes to health behaviour were similar 
to the current study, such as improved diet, increased exercise or changes to vitamins or 
supplements.  When the agreement of the current study with these two previous studies is 
considered along with the difference found between the health behaviours of the consumers and 
potential consumers groups in the current study, the evidence points towards an association 
between receipt of DTC genetic test results and better reported health behaviour for a minority of 
individuals.  The association between receipt of DTC genetic test results and better reported health 
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behaviour may have been due to receipt of the test results, but again it must be emphasized that 
without experimental manipulation no causal effects can be assumed. The results might also be 
explained by underlying differences between those who have taken a genetic test and those who 
have not.  Even if the association is due to receipt of DTC genetic test results, it is unclear whether 
this association is due to the genetic risk information itself, or whether other factors such as 
increased information about diseases and preventative health behaviour could be the cause.   
Although the findings of the current study are contrary to those of Bloss et al. (2011b), the 
difference may be due to the analysis of only two types of health behaviour in their study, compared 
with six in the current study, or due to differences between “real” consumers and individuals offered 
a subsidized test.  No respondents in the current study reported any negative changes to health 
behaviour.  This corresponds with the findings of research into genetic testing for smoking-related 
disease susceptibility, where no evidence of negative effects on health behaviour have been found in 
participants who have tested negative for a gene increasing their risk for a smoking related disease 
(Smerecnik et al. 2012). This finding is noteworthy given the concerns of some commentators that a 
reported low genetic predisposition to disease may discourage healthy behaviour (cf.  Samuel et al. 
2010).   
Interestingly, six participants reported that they had started taking vitamins or dietary supplements, 
a change in health behaviour identified by Roberts et al.(2011) in relation to genetic testing for 
susceptibility to Alzheimer’s disease.  With these results in mind, it may be advisable for future 
studies to analyze a wider range of health behaviours than the current study, including some of the 
behaviours mentioned in the open-ended question on health behaviour change.  As well as 
supplements, these behaviours could perhaps include: preventative checks, reduced caffeine 
consumption and reduced weight. 
The demographics of the respondents of the current study are broadly similar to those in the studies 
reported by Kaufman et al. (2012) and Bloss et al. (2011b).  Namely, participants have been mainly 
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of a white/Caucasian ethnicity, members of a high socioeconomic or income group, possessed a high 
level of education and are in a middle age range.  However, there is some difference in gender, with 
62.7% of participants in the current study self-identifying as male, compared with 54% in the study 
by Kaufman et al. (2012) and 44.7% in the study by Bloss et al. (2011b). 
The findings in relation to health anxiety are less clear than those relating to health behaviour.  
Although many respondents claimed a change in anxiety after receiving their results, no significant 
differences in anxiety levels were found between the consumers and potential consumers groups.  
The lack of a significant difference may signify that any effect the tests have on anxiety are too small 
to be identified with the method used, or that respondents may be inaccurate in their reporting of 
anxiety levels or changes to anxiety.  However, if respondents’ reports of changes to anxiety are 
correct, then a large majority of respondents had no increase in health anxiety.  These results are 
similar to findings from studies investigating the effects of BRCA testing for susceptibility to breast 
cancer and ApoE testing for susceptibility to Alzheimer’s disease (Hilgart et al. 2012; Roberts et al. 
2011).  However, it is important to note that some respondents, albeit a small minority, reported an 
increase in health anxiety. 
No significant correlation was found between perceived risk and health behaviour score, general 
anxiety about health or anxiety about developing a serious disease.  However, it should be noted 
that the design of the question is a limitation.  Consumers were asked about their perception of their 
overall disease risk based on their results.  Because of the complex nature of DTC genetic test 
results, which often show an increased risk for some diseases and a decreased risk for others, it can 
be difficult for consumers to condense their results into an overall impression of their disease risk.  
Therefore it would be inappropriate to draw any conclusions from these findings.  
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Study Limitations  
There are several other limitations to the current study that should be noted.  The method of 
contacting potential participants created a selection bias which excluded non-computer literate 
individuals and those who do not use social media, and may have underrepresented consumers with 
a prior bad experience with the tests.  However, given the small size of the population of consumers 
of DTC genetic tests, social media was the only feasible way to contact “real” consumers whilst 
remaining independent from the providers of DTC genetic tests, and allowed for the inclusion of 
potential consumers in the study.  Also, as consumers need to be reasonably computer literate to 
actually purchase a test (only available through websites), the potential for bias in respect to 
computer literacy should be at a minimum.  A second limitation regards assessing health behaviour.  
As health behaviour was not directly measured, the answers were subjective, and the lack of a 
validated screener item is a major limitation.  Also, the assessment of only six health behaviours 
(four diet-related) in the comparison between the consumers and potential consumers groups may 
have influenced the results, possibly affecting the size of the difference found between the two 
groups, as any difference in other health behaviours (e.g. supplements, preventative checks) 
identified in the open-ended question on health behaviours, would not have been included.  
Another limitation of the study was the lack of a baseline measure, which meant that comparison of 
behaviour before and after receipt of results was not possible.  The lack of a validated or baseline 
measure was also a limitation of the assessment of health anxiety.  Another limitation was caused by 
the combination of respondents who had not yet purchased a test and respondents who had 
purchased a test but not yet received their results into one group.  Although it was assumed that 
these groups were similar, there may have been differences between respondents who had 
purchased a test and those who had only contemplated doing so.  A final limitation of the study is 
that respondents purchased tests from a variety of different DTC genetic testing companies.  Their 
responses may have been influenced by the different disease risks assessed and the different 
methods of reporting results among companies.  A majority of participants purchased a test from 
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one particular company, leaving inadequate statistical power to compare differences between those 
individuals and others who had purchased a test from a different company.       
Practice Implications 
Genetic counsellors are likely to come into contact with patients who have purchased DTC genetic 
tests, and have a role in helping them to understand their results (Gordon et al. 2011).  Although 
there is likely an element of risk to patients’ exposure to genetic risk information (cf. Samuel et al. 
2010), it is important to remember that there is a potential for the test results to have a positive 
impact, and that improvements in health behaviour and reductions in health anxiety may occur.  
Genetic counsellors should aim to provide guidance which will foster these outcomes. 
Research Recommendations 
Future work will involve an in-depth assessment of how the results from DTC genetic tests affect 
behaviour and anxiety amongst “real” consumers.  This will take the form of in-depth interviews of a 
sample of consumers of DTC genetic tests, and will focus on the mechanism by which the genetic risk 
information from a DTC genetic test can affect an individual’s health behaviour or health anxiety.  
This will include an examination of the interaction between health behaviour and health anxiety, and 
will examine factors such as severity of results, surprise caused by results, opinions on quality of 
results, general attitudes towards health, health behaviour and disease, knowledge of genetics and 
utilisation of healthcare in relation to results.   
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